Abbott Laboratories v. Durrett

746 So. 2d 316, 1999 Ala. LEXIS 196, 1999 WL 424338
CourtSupreme Court of Alabama
DecidedJune 25, 1999
Docket1960464
StatusPublished
Cited by22 cases

This text of 746 So. 2d 316 (Abbott Laboratories v. Durrett) is published on Counsel Stack Legal Research, covering Supreme Court of Alabama primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Abbott Laboratories v. Durrett, 746 So. 2d 316, 1999 Ala. LEXIS 196, 1999 WL 424338 (Ala. 1999).

Opinion

746 So.2d 316 (1999)

ABBOTT LABORATORIES et al.
v.
Cecil DURRETT et al.

1960464.

Supreme Court of Alabama.

June 25, 1999.
Rehearing Denied October 22, 1999.

William D. Coleman and Raymond L. Jackson of Capell, Howard, Knabe & Cobbs, P.A., Montgomery, for appellant Ciba-Geigy Corp. and on behalf of all Manufacturer defendants.

Richard H. Gill of Copeland, Franco, Screws & Gill, Montgomery, for appellant Schering-Plough Corp. and on behalf of all Manufacturer defendants.

Lawrence B. Clark and E. Burton Spence of Lange, Simpson, Robinson & Somerville, L.L.P., Birmingham, for appellants.

Joe R. Whatley, Jr., Russell Jackson Drake, and Peter Burke of Cooper, Mitch, Crawford, Kuykendall & Whatley, L.L.C., Birmingham; and Michael Straus and Philippa McC. Bainbridge of Bainbridge & Straus, Birmingham; J. Michael Rediker, Thomas L. Krebs, Steven P. Gregory, and Michael J. Skotnicki of Ritchie & Rediker, Birmingham; David Cromwell Johnson and J. Flint Liddon of Johnson, Liddon, Bear & Tuggle, Birmingham; J.L. Chestnut, Jr., of Chestnut, Sanders, Sanders & Pettaway, P.C., Selma; and T. Roe Frazer II, Richard Freese, and Dennis C. Sweet III of Langston, Frazer, Sweet & Freese, P.A., Jackson, MS, for appellees.

J. Vernon Patrick, Jr., and Jeffrey V. Havercroft of J. Vernon Patrick, Jr. & Assocs., P.C., Birmingham, for Eli Lilly & Co.

Amici curiae:

Tabor R. Novak, Jr., and E. Hamilton Wilson, Jr., of Ball, Ball, Matthews & Novak, P.A., Montgomery, for amici curiae *317 Durr Drug Company and Bergen Brunswig Corp.

Crawford S. McGivaren, Jr., of Cabiness, Johnston, Gardner, Dumas & O'Neal, Birmingham, for amici curiae Cardinal Health, Inc., Whitmire Distribution Corp., Bindley Western Industries, Inc., McKesson Corp., and Amerisource Corp.

Melvin R. Goldman and Lori A. Schechter of Morrison & Foerster, L.L.P., San Francisco, CA; Thomas L. Long of Baker & Hostetler, Columbus, OH; Nada S. Suliaman of Arent Fox Kintner Plotkin & Kahn, Washington, DC; J. Thomas Rosch and Peter K. Huston, San Francisco, CA; and Howard D. Scher and Steven E. Bizar of Montgomery, McCracken, Walker & Rhoads, Philadelphia, PA.

Luther S. Pate IV; Herman Watson, Jr., and Samuel H. Givhan of Watson Jimmerson, P.C., Huntsville, for farming plaintiffs in another case and for "Alabama Farming Businesses"; and Jerry James Wood, Montgomery, for Home Bldrs. Ass'n of Alabama, Inc.

On Rehearing Ex Mero Motu

PER CURIAM.

The opinion of July 31, 1998, is withdrawn and the following is substituted therefor.

The issue presented on this appeal is whether Ala.Code 1975, § 6-5-60, provides a cause of action for damage alleged to have resulted from a conspiracy to control the price of brand-name prescription drugs that were shipped from companies out-of-state into Alabama. The trial court ruled that § 6-5-60 provides such a cause of action; therefore, it denied the defendants' motion for a judgment on the pleadings. We granted the defendants' request for permission to appeal that interlocutory order. Rule 5, Ala.R.App.P. We reverse and remand.

The plaintiffs, individual owners of independent drug stores in Greene and Dallas Counties, filed this action on behalf of themselves and seeking to represent a class consisting of "similarly situated independent retail pharmacists in Alabama who purchase brand-name prescription drugs from the defendant manufacturers and defendant wholesalers at illegally high prices dictated by the discriminatory pricing scheme set by the defendant manufacturers." The defendants are various drug manufacturers, drug wholesalers, health maintenance organizations, and mail-order companies. The complaint alleges that each of the manufacturer and mail-order-company defendants is a foreign corporation with its principal place of business outside Alabama and that the same is true for the majority of the wholesaler defendants. The complaint also alleges that the health-maintenance-organization defendants are Alabama corporations and that they, along with the other defendants, engaged in a conspiracy to control the price of brand-name prescription drugs shipped into Alabama. The plaintiffs allege that they were injured as a result of that conspiracy by being forced to pay the manufacturers and the wholesalers more for the drugs than was paid to those companies by the mail-order companies and the health maintenance organizations, which are alleged to have been "favored purchasers" and an integral part of the price-fixing scheme.

Citing, among other cases, Georgia Fruit Exchange v. Turnipseed, 9 Ala.App. 123, 62 So. 542 (1913); Dothan Oil Mill Co. v. Espy, 220 Ala. 605, 127 So. 178 (1930); Ex parte Rice, 259 Ala. 570, 67 So.2d 825 (1953); San Ann Tobacco Co. v. Hamm, 283 Ala. 397, 217 So.2d 803 (1968); In re Brand Name Prescription Drugs Antitrust Litigation, [No. 94 C 897, October 2, 1996] (N.D.Ill.1996), reversed, 123 F.3d 599 (7th Cir.1997); In re NASDAQ Market Makers Antitrust Litigation, 929 F.Supp. 174, 179 (S.D.N.Y.1996); and Warren v. Playmobil U.S.A., Inc., [CV-95-B-1591-S, March 19, 1996] (N.D.Ala. 1996), the defendants contend that Alabama's antitrust statutes have consistently been interpreted by state and federal courts to apply only to transactions involving intrastate commerce. The defendants argue that Alabama's antitrust statutes, including § 6-5-60, have the same field of operation today that they had when they were first enacted. According to the defendants, the legislative history of Alabama's antitrust statutes, as well as the *318 state of federal caselaw at the time of their enactment, creates a presumption that the Legislature never intended to directly regulate agreements to control the price of goods shipped in interstate commerce. This presumption, the defendants argue, has not been overcome by the plaintiffs.

The plaintiffs contend that § 6-5-60 provides a cause of action in favor of "[a]ny person, firm, or corporation injured or damaged by an unlawful trust, combine or monopoly, or its effect, direct or indirect," and against "any person, firm, or corporation creating, operating, aiding, or abetting such trust, combine, or monopoly." According to the plaintiffs, § 6-5-60 is clear on its face and should not be construed so narrowly as to limit its application to transactions involving intrastate commerce. The plaintiffs maintain, in the alternative, that even if § 6-5-60 should be construed in light of the legislative history of Alabama's antitrust statutes and the state of federal caselaw at the time of their enactment, the clear intent of the Legislature in enacting § 6-5-60 was to regulate all agreements in restraint of trade, whether those agreements involved interstate commerce or intrastate commerce.

With the positions of the parties in mind, we pause to point out what this case is not about. We are not here concerned with whether the Legislature, based on the current state of federal caselaw, has the power to enact a statute, such as § 6-5-60, to provide a means of redress to Alabama companies for indirect injuries suffered as the result of agreements to control the price of goods shipped through interstate commerce. See California v. ARC America Corp., 490 U.S. 93, 109 S.Ct. 1661, 104 L.Ed.2d 86 (1989), cited by the parties for the proposition that the Legislature now has that power.[1] This Court has held that an Alabama statute does not expand like an accordion with changes in federal law bearing on the Legislature's power.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

In re Dealer Management Systems Antitrust Litigation
362 F. Supp. 3d 510 (E.D. Illinois, 2019)
In re Propranolol Antitrust Litigation
249 F. Supp. 3d 712 (S.D. New York, 2017)
Jefferson County Commission v. Edwards
32 So. 3d 572 (Supreme Court of Alabama, 2009)
Freeman Industries, LLC v. Eastman Chemical Co.
172 S.W.3d 512 (Tennessee Supreme Court, 2005)
Olstad v. Microsoft Corporation
2005 WI 121 (Wisconsin Supreme Court, 2005)
Marks v. Tenbrunsel
910 So. 2d 1255 (Supreme Court of Alabama, 2005)
In re Linerboard Antitrust Litigation
223 F.R.D. 335 (E.D. Pennsylvania, 2004)
Mobile Infirmary Medical Center v. Hodgen
884 So. 2d 801 (Supreme Court of Alabama, 2003)
Brown v. BOARD OF EDUC. OF MONTG. COUNTY
863 So. 2d 73 (Supreme Court of Alabama, 2003)
Brown v. Board of Education
863 So. 2d 73 (Supreme Court of Alabama, 2003)
Griffiths v. Blue Cross and Blue Shield of Alabama
147 F. Supp. 2d 1203 (N.D. Alabama, 2001)
Daniel Sherwood v. Microsoft
Court of Appeals of Tennessee, 2001
Freeman v. DUPONT PHARMACEUTICALS CO.
790 So. 2d 248 (Supreme Court of Alabama, 2001)
South Central Bell Telephone Co. v. State
789 So. 2d 133 (Supreme Court of Alabama, 1999)
Archer Daniels Midland Co. v. Seven Up Bottling Co.
746 So. 2d 966 (Supreme Court of Alabama, 1999)

Cite This Page — Counsel Stack

Bluebook (online)
746 So. 2d 316, 1999 Ala. LEXIS 196, 1999 WL 424338, Counsel Stack Legal Research, https://law.counselstack.com/opinion/abbott-laboratories-v-durrett-ala-1999.